| scholarly article | Q13442814 |
| P2093 | author name string | C van Delden | |
| C-A Siegrist | |||
| I Katerinis | |||
| J Villard | |||
| K Hadaya | |||
| P-Y Martin | |||
| R Duquesnoy | |||
| S Ferrari-Lacraz | |||
| S Meier | |||
| P2860 | cites work | Gapped BLAST and PSI-BLAST: a new generation of protein database search programs | Q24545170 |
| Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling | Q24684997 | ||
| Molecular and cellular signatures of human vaccine adjuvants. | Q30370898 | ||
| Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. | Q30380578 | ||
| Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. | Q30381923 | ||
| Humoral theory of transplantation | Q35142603 | ||
| Heterologous immunity: an overlooked barrier to tolerance | Q35583521 | ||
| A structurally based approach to determine HLA compatibility at the humoral immune level | Q36316220 | ||
| Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression | Q36475908 | ||
| Effects of influenza immunization on humoral and cellular alloreactivity in humans | Q36661931 | ||
| Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
| Immunology of TLR-independent vaccine adjuvants | Q37506781 | ||
| Influenza virus infection in adult solid organ transplant recipients | Q40579386 | ||
| Association of renal allograft rejection with virus infections | Q40906023 | ||
| Influenza vaccination in kidney transplant recipients: cellular and humoral immune responses. | Q50590166 | ||
| Thrombotic Microangiopathy After Kidney Transplantation | Q57702140 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| immunization | Q1415366 | ||
| pandemic | Q12184 | ||
| P304 | page(s) | 1727-1733 | |
| P577 | publication date | 2011-06-14 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients | |
| P478 | volume | 11 |
| Q30401136 | Adjuvanted (AS03) A/H1N1 2009 Pandemic Influenza Vaccines and Solid Organ Transplant Rejection: Systematic Signal Evaluation and Lessons Learnt. |
| Q30356208 | Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients. |
| Q30420230 | Antibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients |
| Q34901704 | Behaviour of non-donor specific antibodies during rapid re-synthesis of donor specific HLA antibodies after antibody incompatible renal transplantation. |
| Q38225998 | Changing face of vaccination in immunocompromised hosts |
| Q39290443 | Clinical Characteristics and Outcomes of Influenza A Infection in Kidney Transplant Recipients: A Single-Center Experience |
| Q38265563 | Clinical relevance of HLA antibody monitoring after kidney transplantation |
| Q30383985 | Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series |
| Q94416613 | Guidelines for vaccination in kidney transplant recipients |
| Q42270590 | HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages |
| Q35097898 | HLA sensitisation: can it be prevented? |
| Q40617701 | Heterologous Immune Responses to Influenza Vaccine in Kidney Transplant Recipients. |
| Q51419717 | Humoral immunomodulatory effect of influenza vaccine in potential blood donors: implications for transfusion safety. |
| Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
| Q38235003 | Immunization after kidney transplantation-what is necessary and what is safe? |
| Q37320197 | Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review |
| Q42239771 | Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients |
| Q30430823 | Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients |
| Q36832305 | Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients |
| Q30372284 | Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. |
| Q39440909 | Infectious pathogens may trigger specific allo-HLA reactivity via multiple mechanisms. |
| Q38602985 | Influenza and other respiratory virus infections in solid organ transplant recipients |
| Q42220410 | Influenza vaccination and humoral alloimmunity in solid organ transplant recipients |
| Q30358640 | Influenza vaccination in immunocompromised patients: efficacy and safety. |
| Q37940524 | Influenza vaccination in the organ transplant recipient: review and summary recommendations. |
| Q35633460 | Influenza virus vaccination and kidney graft rejection: causality or coincidence |
| Q47841676 | Males without apparent alloimmunization could have HLA antibodies that recognize target HLA specificities expressed on cells. |
| Q30416238 | Optimizing the immunogenicity of pandemic H1N1 2009 influenza vaccine in adult organ transplant patients |
| Q38596671 | Pediatric deceased donor renal transplantation: An approach to decision making II. Acceptability of a deceased donor kidney for a child, a snap decision at 3 AM. |
| Q38168902 | Pneumococcal immunization in immunocompromised hosts: where do we stand? |
| Q30421507 | Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients. |
| Q42272300 | RNA respiratory viruses in solid organ transplantation |
| Q51831461 | Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. |
| Q35811966 | Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease |
| Q47583282 | Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation |
| Q39741902 | Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series. |
| Q91577533 | Safety of AS03-adjuvanted influenza vaccines: A review of the evidence |
| Q54265837 | Seasonal influenza vaccine in immunocompromised persons. |
| Q37965366 | TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition. |
| Q30409959 | The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients |
| Q30356534 | The effect of adjuvant H1N1 influenza vaccine on allograft kidney function. |
| Q38734701 | The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia. |
| Q40270352 | Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial |
| Q35790601 | Utility of HLA Antibody Testing in Kidney Transplantation |
| Q42272271 | Vaccination in solid organ transplantation |
| Q38207911 | Washing red cells after leucodepletion does not decrease human leukocyte antigen sensitization risk in patients with chronic kidney disease |
| Q85502405 | Whether or not to accept a deceased donor kidney offer for a pediatric patient |
Search more.